Rankings
▼
Calendar
VRCA FY 2018 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
$57M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$20,294
Operating Income
-$22M
Net Income
-$21M
EPS (Diluted)
$-14.08
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$19M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$92M
Total Liabilities
$2M
Stockholders' Equity
$89M
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$20,294
$0
—
Operating Income
-$22M
-$4M
-390.9%
Net Income
-$21M
-$4M
-363.1%
← Q4 2017
All Quarters
Q1 2018 →